These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14706552)

  • 1. Human galanin expresses amphipathic properties that modulate its vasoreactivity in vivo.
    Dagar S; Onyüksel H; Akhter S; Krishnadas A; Rubinstein I
    Peptides; 2003 Sep; 24(9):1373-80. PubMed ID: 14706552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles.
    Ashok B; Rubinstein I; Tsueshita T; Onyüksel H
    Peptides; 2004 Aug; 25(8):1253-8. PubMed ID: 15350692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo.
    Gandhi S; Tsueshita T; Onyüksel H; Chandiwala R; Rubinstein I
    Peptides; 2002 Aug; 23(8):1433-9. PubMed ID: 12182944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospholipids modulate the biophysical properties and vasoactivity of PACAP-(1--38).
    Tsueshita T; Gandhi S; Onyüksel H; Rubinstein I
    J Appl Physiol (1985); 2002 Oct; 93(4):1377-83. PubMed ID: 12235038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformation and vasoreactivity of VIP in phospholipids: effects of calmodulin.
    Rubinstein I; Patel M; Ikezaki H; Dagar S; Onyüksel H
    Peptides; 1999 Dec; 20(12):1497-501. PubMed ID: 10698126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal VIP attenuates phenylephrine- and ANG II-induced vasoconstriction in vivo.
    Ikezaki H; Onyüksel H; Rubinstein I
    Am J Physiol; 1998 Aug; 275(2):R588-95. PubMed ID: 9688697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. All D-VIP mitigates vasodilation elicited by L-VIP, micellar L-VIP and micellar PACAP1-38, but not PACAP1-38, in vivo.
    Rubinstein I; Ashok B; Tsueshita T; Onyüksel H
    Peptides; 2005 Mar; 26(3):509-15. PubMed ID: 15652658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of vasodilation elicited by VIP in sterically stabilized liposomes in vivo.
    Séjourné F; Suzuki H; Alkan-Onyüksel H; Gao XP; Ikezaki H; Rubinstein I
    Am J Physiol; 1997 Jul; 273(1 Pt 2):R287-92. PubMed ID: 9249562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of thromboxane receptors and the induction of vasomotion in the hamster cheek pouch microcirculation.
    Verbeuren TJ; Vallez MO; Lavielle G; Bouskela E
    Br J Pharmacol; 1997 Nov; 122(5):859-66. PubMed ID: 9384501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity.
    Onyüksel H; Ashok B; Dagar S; Sethi V; Rubinstein I
    Peptides; 2003 Feb; 24(2):281-6. PubMed ID: 12668213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exogenous calmodulin potentiates vasodilation elicited by phospholipid-associated VIP in vivo.
    Ikezaki H; Patel M; Onyüksel H; Akhter SR; Gao XP; Rubinstein I
    Am J Physiol; 1999 May; 276(5):R1359-65. PubMed ID: 10233028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel formulation of VIP in sterically stabilized micelles amplifies vasodilation in vivo.
    Onyüksel H; Ikezaki H; Patel M; Gao XP; Rubinstein I
    Pharm Res; 1999 Jan; 16(1):155-60. PubMed ID: 9950295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium on the vasoactive response of arterioles to light during fluorescent intravital microscopy of the tibialis anterior muscle of the hamster.
    Messina LM; Gardner A
    Microvasc Res; 1992 Nov; 44(3):274-85. PubMed ID: 1479928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P-450 omega-hydroxylase senses O2 in hamster muscle, but not cheek pouch epithelium, microcirculation.
    Lombard JH; Kunert MP; Roman RJ; Falck JR; Harder DR; Jackson WF
    Am J Physiol; 1999 Feb; 276(2):H503-8. PubMed ID: 9950851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidases modulate bradykinin-induced arteriolar dilation in the hamster cheek pouch.
    Gao XP; Anding P; Robbins RA; Rennard SI; Rubinstein I
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H93-8. PubMed ID: 8304527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term exposure to lipopolysaccharide is associated with microvascular contractile dysfunction in vivo.
    Gao XP; Suzuki H; Olopade CO; Rubinstein I
    Life Sci; 1995 Mar; 56(15):1243-9. PubMed ID: 8614241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute infusion of nicotine potentiates norepinephrine-induced vasoconstriction in the hamster cheek pouch.
    Mayhan WG
    J Lab Clin Med; 1999 Jan; 133(1):48-54. PubMed ID: 10385481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.
    Hall JM; Brain SD
    Br J Pharmacol; 1994 Oct; 113(2):522-6. PubMed ID: 7530573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action.
    Dillon PK; Ritter AB; Durán WN
    Circ Res; 1988 Apr; 62(4):722-31. PubMed ID: 2832096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasodilation elicited by liposomal VIP is unimpeded by anti-VIP antibody in hamster cheek pouch.
    Ikezaki H; Paul S; Alkan-Onyüksel H; Patel M; Gao XP; Rubinstein I
    Am J Physiol; 1998 Jul; 275(1):R56-62. PubMed ID: 9688960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.